Case report shows improvement in hypoxemia and pulmonary hypertension in interstitial lung disease, indicating inhaled treprostinil's potential benefit.
Key Points
Patient with acute exacerbation of interstitial lung disease showed improvement after treatment with inhaled treprostinil.
Despite high-dose corticosteroids and other treatments, significant hypoxemia persisted until inhaled treprostinil was introduced.
Case report indicates potential for inhaled treprostinil to help manage pulmonary hypertension associated with interstitial lung disease.
This case highlights the need for further studies to establish firm clinical recommendations for using inhaled treprostinil.